These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 28888180)
1. Density of tubal ring vascularization: A new marker for prediction of success of medical treatment in tubal ectopic pregnancy. Aydoğmuş S; Aydoğmuş H; Gençdal S; Kelekçi S Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():113-118. PubMed ID: 28888180 [TBL] [Abstract][Full Text] [Related]
2. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study. Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362 [TBL] [Abstract][Full Text] [Related]
3. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. Elito J; Reichmann AP; Uchiyama MN; Camano L Int J Gynaecol Obstet; 1999 Nov; 67(2):75-9. PubMed ID: 10636050 [TBL] [Abstract][Full Text] [Related]
4. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy. Yıldız A; Bilge O Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015 [TBL] [Abstract][Full Text] [Related]
5. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy. Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534 [TBL] [Abstract][Full Text] [Related]
6. Nonsurgical management of live tubal ectopic pregnancy by ultrasound-guided local injection and systemic methotrexate. Wang M; Chen B; Wang J; Ma X; Wang Y J Minim Invasive Gynecol; 2014; 21(4):642-9. PubMed ID: 24462855 [TBL] [Abstract][Full Text] [Related]
7. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy. Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603 [TBL] [Abstract][Full Text] [Related]
8. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study. Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360 [TBL] [Abstract][Full Text] [Related]
10. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF. Marret H; Fauconnier A; Dubernard G; Misme H; Lagarce L; Lesavre M; Fernandez H; Mimoun C; Tourette C; Curinier S; Rabishong B; Agostini A Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():105-9. PubMed ID: 27572300 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial. Silva PM; Araujo Júnior E; Cecchino GN; Elito Júnior J; Camano L Arch Gynecol Obstet; 2015 Apr; 291(4):939-43. PubMed ID: 25315383 [TBL] [Abstract][Full Text] [Related]
12. Management of ectopic pregnancies with poor prognosis through ultrasound guided intrasacular injection of methotrexate, series of 14 cases. Andrés MP; Campillos JM; Lapresta M; Lahoz I; Crespo R; Tobajas J Arch Gynecol Obstet; 2012 Feb; 285(2):529-33. PubMed ID: 21837423 [TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases. Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702 [TBL] [Abstract][Full Text] [Related]
14. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies. Goh A; Karine P; Kirby A; Williams C; Kapurubandara S Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399 [TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic endometrial features in tubal pregnancy: are they predictive factors of successful medical treatment? Lim JE; Kim T; Lee NW; Oh MJ; Seol HJ; Jung NH; Park SH; Jung SE; Park IH; Kim HJ Ultrasound Med Biol; 2007 May; 33(5):714-9. PubMed ID: 17412483 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis. Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445 [TBL] [Abstract][Full Text] [Related]
18. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted? Tug N; Sargin MA; Yassa M Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453 [TBL] [Abstract][Full Text] [Related]
19. A new predictive scoring system including shock index for unruptured tubal pregnancy patients. Kahyaoglu S; Turgay I; Gocmen M; Sut N; Batioglu S Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):99-103. PubMed ID: 16246482 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Cohen A; Zakar L; Gil Y; Amer-Alshiek J; Bibi G; Almog B; Levin I Am J Obstet Gynecol; 2014 Aug; 211(2):128.e1-5. PubMed ID: 24657132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]